Check 35,000+ stocks against 26 valuation models and 37 quality factors

Bimi International Medical Inc (BIMI) fair value: what the stock is really worth

As of Sep 22, 2026: fair value of Bimi International Medical Inc $0.00, price $0.00, upside +0.0%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? No
Add to watchlist

Healthcare · US · ISIN US05552Q2021

Thin data Sep 27, 2026

Bimi International Medical Inc

BIMI · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.0002 · Fairly valued (+0.0%)

!Quality 33/100

!Mixed Growth (revenue 5y +14.1 %/yr)

!Loss-making · -83.2% net margin (TTM)

!Low debt · negative free cash flow

!Trails peers (0/8)

!Narrow moat 3/100

!Evidence only low, so the estimate is less certain

26 models, one by onewith weight and evidence Growth analysisrevenue history, year by year Quality 33/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Bimi International Medical Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range $0.0001 – $155.00 · the $0.0002 price screens below the $0.0002 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Bimi International Medical in your weekly email

Every Wednesday you see whether Bimi International Medical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York.

Stock analysis

Bimi International Medical Inc (BIMI) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0002, so the stock looks roughly fairly valued today (gap 0.0%).

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 83/100, which puts the evidence level at low.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Bimi International Medical Inc reported revenue of $12.6M in FY2023 versus $158K in FY2019, a compound +199.0%/yr. Reported net income was −$10.5M in FY2023.

Key figures

Market cap $1.4K · EPS (TTM) $−6.39 · Net margin −83.2% · Return on equity −104% · Return on assets (EBIT) −19.7% · Operating margin −125% · Revenue (TTM) $12.6M · Revenue growth (YoY) −48.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades about 60% below its 52-week high and 100% above its 52-week low.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at 0%, BIMI screens richer than that median.

Fair Value models

Bear $0.0002 Fair Value $0.0002 Bull $0.0002

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

NCAV (Graham) $0.0001 $0.0002 $0.0003 53

All 1 models by family

Asset-Based

NCAV (Graham) $0.0001 $0.0002 $0.0003 53

Open the full fair value analysis →

Notify me when BIMI reaches fair value

Put BIMI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 33 · Market factors (momentum, volatility) 35

Profitability 9

Margins and returns on capital today

Quality Growth 82

Are margins and returns improving?

Cashflow 25

Earnings quality: real cash, not paper profit

Fin. Strength 24

Balance sheet, leverage, solvency risk

Investment 90

Disciplined investing over empire-building

Low Volatility 50

Calm price path (market factor)

Momentum 46

Price trend over the last 3–12 months (market factor)

52W Momentum 0

Distance to the 52-week high (market factor)

Net Issuance 0

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 36/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+6.8%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−0.6%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+14.1%

Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+62.0%

’11

’12

’13

’14

’15

’16

’17

’18

’20

’21

’22

’23

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−241.4% (2018) → −30.2% (2023)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2022 is a loss year, no rate is defined from a loss

not computed

Watch BIMI, get fair value alerts →

Compare Bimi International Medical Inc with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 54 stocks

Beats the industry median on 0/7 measures

Overall it trails its industry peers.

Valuation

Quality Score 33 · Bottom 25%

Fair Value upside +0.0% · Below median

Profitability

Return on assets −13.0% · Bottom 25%

Net margin (TTM) −83.2% · Bottom 25%

Operating margin (TTM) −124.8% · Bottom 25%

Growth and dividend

Revenue growth −48.8% · Bottom 25%

Balance sheet

Debt / equity 0.08× · Above median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)33 · sector 45

FUTURE (revenue growth)0 · sector 18

PAST (return on equity)0 · sector 22

HEALTH (low debt)96 · sector 96

DIVIDEND (yield)0 · sector 65

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Alibaba Health Information Technology Limited 0241	HK$2.83	HK$2.34	−17%
Yifeng Pharmacy Chain Co 603939	¥22.08	¥40.59	+84%
DaShenLin Pharmaceutical Group 603233	¥17.83	¥26.45	+48%
LBX Pharmacy Chain Joint Stock Company 603883	¥13.04	¥14.34	+10%
Yixintang Pharmaceutical Group 002727	¥10.60	¥9.51	−10%
ShuYu Civilian Pharmacy Corp 301017	¥14.84	¥5.91	−60%
Anhui Huaren Health Pharmaceutical Co 301408	¥14.93	¥16.42	+10%
Apotea AB APOTEA	kr 85.25	kr 46.46	−46%
MedPlus Health Services Limited MEDPLUS	₹654.30	₹393.38	−40%
Luyan Pharma Co 002788	¥10.76	¥15.91	+48%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Bimi International Medical Inc · Fair Value
$0.0002 +0%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/BIMI" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Bimi International Medical Inc · Fair Value</span><br><b style="font-size:20px">$0.0002</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+0%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Bimi International Medical Inc Fair Value". https://www.fairvalue-calculator.com/stock/BIMI

Frequently asked questions

Is Bimi International Medical Inc (BIMI) overvalued or undervalued?

As of Sep 27, 2026, our model estimates a fair value of $0.0002 versus the last price from Sep 22, 2026 of $0.0002, about +0% upside (fairly valued).

What is the fair value of BIMI?

Our model-based fair value for Bimi International Medical Inc is $0.0002 (as of Sep 27, 2026), built from audited fundamentals. Last price (from Sep 22, 2026): $0.0002.

What is the quality score of BIMI?

Bimi International Medical Inc has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Bimi International Medical Inc (BIMI)?

Our model-based price target is the fair value of $0.0002 (as of Sep 27, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.

What is the Bimi International Medical Inc stock forecast for 2026?

Our models put fair value at $0.0002, about +0% upside versus the last price from Sep 22, 2026 of $0.0002 (fairly valued). The calculation is refreshed regularly with new filings.

What is the revenue of Bimi International Medical Inc (BIMI)?

Bimi International Medical Inc reported trailing-twelve-month revenue of about $12.6M (latest available figure, as of Sep 27, 2026).

What is the intrinsic value of Bimi International Medical Inc (BIMI)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bimi International Medical Inc it is $0.0002 per share (as of Sep 27, 2026), against a price of $0.0002. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).

Is Bimi International Medical Inc stock overvalued or undervalued in 2026?

As of Sep 27, 2026, BIMI trades below its calculated fair value: price $0.0002, fair value $0.0002, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of BIMI?

No. The price is what the market pays today ($0.0002); the fair value is what the company's own numbers justify ($0.0002). For Bimi International Medical Inc the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.

How much is Bimi International Medical Inc worth?

The market values Bimi International Medical Inc at about $1.4K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0002; our models calculate a fair value of $0.0002 per share.

How solid is the balance sheet of Bimi International Medical Inc (BIMI)?

Balance-sheet figures for Bimi International Medical Inc (as of Sep 27, 2026): return on equity −103.8%, debt of 0.08 per unit of equity. They feed the Quality Score of 33/100, which measures business quality independently of the share price.

How far is BIMI from its 52-week high?

Bimi International Medical Inc trades at $0.0002, about 60% below its 52-week high of $0.0005 and 100% above the low of $0.0001 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0002 is for.

Which stocks are comparable to Bimi International Medical Inc?

From the same area (Healthcare) we also value Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, LBX Pharmacy Chain Joint Stock Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Bimi International Medical Inc stock attractive at the current price?

The data as of Sep 27, 2026: price $0.0002, calculated fair value $0.0002 (+0%), Quality Score 33/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of BIMI calculated?

We run Bimi International Medical Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0002, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. Bimi International Medical Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Bimi International Medical Inc (BIMI)?

The latest price we hold is from Sep 22, 2026 and stands at $0.0002. Our model-based fair value is $0.0002, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Bimi International Medical Inc right now?

The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Bimi International Medical Inc

How large is the market capitalisation of Bimi International Medical Inc (BIMI)?

The market capitalisation of Bimi International Medical Inc is $1.4K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What are the earnings per share of Bimi International Medical Inc (BIMI)?

Earnings per share at Bimi International Medical Inc are $−6.39. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Bimi International Medical Inc (BIMI)?

The net margin of Bimi International Medical Inc is −83.2% (fiscal year 2023). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Bimi International Medical Inc (BIMI)?

The return on equity (ROE) of Bimi International Medical Inc is −104% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Bimi International Medical Inc (BIMI)?

On an EBIT basis the return on assets of Bimi International Medical Inc is −19.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Bimi International Medical Inc (BIMI)?

The operating margin of Bimi International Medical Inc is −125% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Bimi International Medical Inc (BIMI)?

Revenue at Bimi International Medical Inc is growing −48.8% versus a year earlier (3y avg −0.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How much free cash flow does Bimi International Medical Inc (BIMI) generate?

The free cash flow of Bimi International Medical Inc is −$3.5M (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does Bimi International Medical Inc (BIMI) carry?

The net debt of Bimi International Medical Inc is $3.1M (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Bimi International Medical Inc in the live analysis

One click puts Bimi International Medical Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.